3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Ewing
1
Sarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Lymphoma, Follicular
1
Genetic Predisposition to Disease
1
Interventions
Cyclophosphamide
16
Temozolomide
13
Vincristine
10
Irinotecan
8
Melphalan
7
Doxorubicin
7
Topotecan
6
Granulocyte Colony-Stimulating Factor
6
Busulfan
6
fludarabine
5
cabozantinib
5
Etoposide
5
Drug Therapy
5
liposomal doxorubicin
4
Sirolimus
4
Ifosfamide
4
Filgrastim
4
regorafenib
3
pegfilgrastim
3
irinotecan sucrosofate
3
fludarabine phosphate
3
Zoledronic Acid
3
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Cisplatin
3
Bone Marrow Transplantation
3
Albumin-Bound Paclitaxel
3
pegylated granulocyte colony-stimulating factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma, Ewing
×
Genome-Wide Association Study
×
Clear all
NCT01210209
2021-05-19
GENEWING
Institut Curie
Completed
350 enrolled